Endometriosis Diagnosis — A Structured Pathway

Average global diagnostic delay in endometriosis is 7–10 years. Modern diagnosis combines structured clinical assessment, expert pelvic ultrasound using the ISUOG IDEA consensus protocol, selective MRI for deep disease, and laparoscopy only when it changes management. This page describes the diagnostic pathway in detail.

1. Clinical history and examination

Detailed symptom history including pain pattern (cyclical, progressive, location, severity), dyspareunia, bowel and bladder symptoms, fertility status, menstrual pattern, family history. Bimanual pelvic examination for tender nodularity in pouch of Douglas, uterosacral ligaments, rectovaginal septum. Speculum examination for visible vaginal forniceal lesions in deep disease.

2. Transvaginal ultrasound — IDEA consensus protocol

The ISUOG IDEA (International Deep Endometriosis Analysis) consensus protocol systematically maps four compartments: anterior (bladder, uterovesical fold), posterior (uterosacrals, rectovaginal septum, anterior rectum), ovaries (endometriomas, mobility), and uterus (adenomyosis features, junctional zone). Expert ultrasound detects most deep infiltrating disease without surgery.

3. Findings on expert ultrasound

Endometrioma: typical ground-glass homogeneous echogenic content. Deep infiltrating endometriosis nodules: hypoechoic, often with regular or irregular margins, in characteristic locations. Bowel involvement: focal bowel wall thickening, loss of layered architecture, tethering of bowel. Site-specific mapping allows surgical planning.

4. MRI mapping

Pelvic MRI adds detail for deep infiltrating disease, particularly bowel, bladder and ureteric involvement. Standard sequences plus rectal/vaginal contrast in selected cases. MRI quantifies lesion size, depth, distance from anal verge (critical for bowel surgical planning), and identifies thoracic endometriosis on extended sequences if symptoms suggest.

5. CA-125 and biomarkers

Serum CA-125 can be modestly elevated in endometriosis but is non-specific and not recommended for diagnosis. False positives occur in PID, fibroids, menstruation. False negatives in mild disease. CA-125 has no role in primary endometriosis diagnosis per ESHRE 2022 guidance; it is used selectively to monitor known disease in specific situations.

6. AMH and ovarian reserve

For any reproductive-age patient with suspected or confirmed endometriosis, AMH and antral follicle count establish baseline ovarian reserve. Critical before any ovarian surgery. Endometriomas, especially bilateral, may already have reduced reserve. Tracking AMH at 3 months post-intervention quantifies surgical impact.

7. When laparoscopy is needed

Modern practice has moved away from diagnostic laparoscopy alone. Laparoscopy is reserved for cases where imaging is normal but symptoms strongly suggest endometriosis (typically combined with surgical treatment in the same session), or where definitive histology will change management. Routine “diagnostic laparoscopy” is no longer standard.

8. Communicating the diagnosis

Diagnosis communicated clearly with imaging shown. Stage discussed using rASRM and where applicable ESGE #Enzian classification. Prognosis framed honestly. Treatment options explored — medical management, surgery, IVF — with evidence base. Written summary provided. Time taken to ensure understanding before treatment decisions.

Frequently Asked Questions

Dr. Priyadatt Patel

Senior Gynecologist · Advanced Laparoscopic Surgeon · IVF and Endometriosis Programme Lead

MS OBGyn · Pregnancy Care · Advanced Gynaecological Ultrasound · Fertility Preservation

ESHRE / ESGE / AAGL / ASRM guideline-aligned practice. 3D Karl Storz precision technique. Fertility-preservation-first philosophy. Evidence-based decisions, honest counselling, long-term outcomes orientation.